Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Moiola

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Multiple Sclerosis and Related Disorders|February 15, 2022
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infectionDoriana Landi, Gaia Cola, Vittorio Mantero, et al.
Molecular Neurobiology|June 8, 2024
Genetic Contribution to Medium-Term Disease Activity in Multiple SclerosisElisabetta Mascia, Valentina Nale, Laura Ferrè, et al.
Neurology|August 20, 2017
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patientsErmelinda De Meo, Lucia Moiola, Angelo Ghezzi, et al.
Molecular Psychiatry|October 14, 2020
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairmentRaffaello Bonacchi, Maria A Rocca, Giuseppe A Ramirez, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patientsGiulia Mallucci, Francesco Patti, Vincenzo Brescia Morra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesionsMaria A Rocca, Ermelinda De Meo, Maria P Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2009
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceAngelo Ghezzi, Maria Pia Amato, Pietro Annovazzi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease predictionFederica Esposito, Clara Guaschino, Melissa Sorosina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2015
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosisMaria A Rocca, Maria E Morelli, Maria P Amato, et al.
Neurology|March 21, 2014
Posterior brain damage and cognitive impairment in pediatric multiple sclerosisMaria A Rocca, Martina Absinta, Maria Pia Amato, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Multiple Sclerosis and Related Disorders|February 15, 2022
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infectionDoriana Landi, Gaia Cola, Vittorio Mantero, et al.
Molecular Neurobiology|June 8, 2024
Genetic Contribution to Medium-Term Disease Activity in Multiple SclerosisElisabetta Mascia, Valentina Nale, Laura Ferrè, et al.
Neurology|August 20, 2017
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patientsErmelinda De Meo, Lucia Moiola, Angelo Ghezzi, et al.
Molecular Psychiatry|October 14, 2020
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairmentRaffaello Bonacchi, Maria A Rocca, Giuseppe A Ramirez, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patientsGiulia Mallucci, Francesco Patti, Vincenzo Brescia Morra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesionsMaria A Rocca, Ermelinda De Meo, Maria P Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2009
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceAngelo Ghezzi, Maria Pia Amato, Pietro Annovazzi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease predictionFederica Esposito, Clara Guaschino, Melissa Sorosina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2015
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosisMaria A Rocca, Maria E Morelli, Maria P Amato, et al.
Neurology|March 21, 2014
Posterior brain damage and cognitive impairment in pediatric multiple sclerosisMaria A Rocca, Martina Absinta, Maria Pia Amato, et al.
Pageof 16